2 results
Approved WMOWill not start
Primary Objectives* Phase 1b lead-in: To assess safety and tolerability of a single dose level of avelumab in combination withincreasing dose levels of other immune modulators in combination with a single doselevel of avelumab in patients with…
Approved WMOCompleted
Studies to date have demonstrated a reduction in HF-related hospitalizations and improved quality of life in patients using the CardioMEMS HF System when compared with patients receiving standard of care in the United States. The purpose of this…